Antioxidant probucol as an effective scavenger of lipid radicals in low density lipoproteinsin vivo andin vitro

Measurement of Plasma Hydroperoxide Concentrations by the Ferrous Oxidation-Xylenol Orange Assay in Conjunction with Triphenylphosphine

Jaffar Nourooz‐Zadeh, Simon P. Wolff · Analytical Biochemistry · 1994 · 675 citations

Life Sciences, Chemistry, Toxicology +8

Effectiveness of an Antioxidant in Preventing Restenosis After Percutaneous Transluminal Coronary Angioplasty: The Probucol Angioplasty Restenosis Trial

Hisashi Yokoi, Hiroyuki Daida, Yoichi Kuwabara et al. · Journal of the American College of Cardiology · 1997 · 185 citations

Medicine, Cardiology, Pharmacotherapy +16

Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol.

Shuqi Mao, Mark T. Yates, Richard Parker et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1991 · 104 citations · Full text

Life Sciences, Pharmacology, Cardiovascular Pharmacotherapy +16

Prevention of Restenosis After Angioplasty in Small Coronary Arteries With Probucol

Josep Rodés, Gilles Côté, Jacques Lespérance et al. · Circulation · 1998 · 89 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Apolipoprotein B-Bound Lipids as a Marker for Evaluation of Low Density Lipoprotein Oxidation in Vivo

V.V. Tertov, V.V. Kaplun, S. N. Dvoryantsev et al. · Biochemical and Biophysical Research Communications · 1995 · 64 citations

Life Sciences, Biochemistry, Lipid Biochemistry +11